Tegafur-uracil-induced rapid development of advanced hepatic fibrosis

doi:10.3748/wjg.v23.i31.5823

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 31

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6561)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

761

WORD

207

HTML

2562

Figures (1-4)

196

Tables (1-2)

161

Sum=3887

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1193

Download

1481

Sum=2674

Aug 21, 2017 (publication date) through Aug 25, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Aug 21, 2017; 23(31): 5823-5828
Published online Aug 21, 2017. doi: 10.3748/wjg.v23.i31.5823

Full Size Figure Download Figure

Figure 4 Clinical course. Serum ALT levels increased after the administration of tegafur-uracil. With liver-supporting treatment, the serum ALT levels temporarily improved. However, serum ALT levels increased again, and the patient was referred to our hospital after 8 mo. Discontinuation of tegafur-uracil combined with conservative treatment improved serum ALT levels, platelet counts, and prothrombin activity. PT%: Prothrombin time; ALT: Alanine aminotransferase.

Citation: Honda S, Sawada K, Hasebe T, Nakajima S, Fujiya M, Okumura T. Tegafur-uracil-induced rapid development of advanced hepatic fibrosis. World J Gastroenterol 2017; 23(31): 5823-5828
URL: https://www.wjgnet.com/1007-9327/full/v23/i31/5823.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i31.5823